Polycaprolactone scaffold engineered for sustained release of resveratrol: Therapeutic enhancement in bone tissue engineering

International Journal of Nanomedicine

Volumn 9, Issue 1, 2013, Pages 183-195

  Kamath, Manjunath Srinivas ^a   Ahmed, Shiek S S J ^b   Dhanasekaran, M ^c   Winkins Santosh, S ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b CHETTINAD HOSPITAL AND RESEARCH INSTITUTE   (India)

^c Life Line Rigid Hospital Pvt Ltd   (India)

Author keywords

Albumin nanoparticles; Bone tissue engineering; Mesenchymal stem cells; Polycaprolactone scaffolds; Resveratrol; Therapeutic scaffolds

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; NANOPARTICLE; POLYCAPROLACTONE; RESVERATROL;

ADULT; ARTICLE; BONE REGENERATION; CALCIFICATION; CONTROLLED STUDY; DISPERSION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MESENCHYMAL STEM CELL; MINERALIZATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE PREPARATION; TISSUE ENGINEERING; X RAY DIFFRACTION; ZETA POTENTIAL;

ALBUMIN NANOPARTICLES; BONE TISSUE ENGINEERING; MESENCHYMAL STEM CELLS; POLYCAPROLACTONE SCAFFOLDS; RESVERATROL; THERAPEUTIC SCAFFOLDS;

BONE REGENERATION; CELLS, CULTURED; DRUG IMPLANTS; HUMANS; MESENCHYMAL STROMAL CELLS; NANOPARTICLES; OSTEOGENESIS; POLYESTERS; POROSITY; STILBENES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84891512464     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S49460     Document Type: Article

References (25)

1. Keating JF, Simpson AH, Robinson CM. The management of fractures with bone loss. J Bone Joint Surg Br. 2005;87:142-150.
2. Mitchel SE, Keating JF, Robinson CM. The treatment of open femoral fractures with bone loss. J Bone Joint Surg Br. 2010;92:1678-1684.
3. Thayur RM, Balasundaram R, Manjunath KS, Harshad MS, Dabir CS, Krishnappa N. Outcomes of Ilizarov ring fixation in recalcitrant infected tibial non-unions - a prospective study. J Trauma Manag Outcomes. 2008;2:6.
4. Nuss KM, von Rechenberg B. Biocompatibility issues with modern implants in bone - a review for clinical orthopedics. Open Orthop J. 2008;2:66-78.
5. Kim DH, Rhim R, Li L, et al. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J. 2009;9:886-892.
6. Rangasamy J, Krishna PC, Sowmya S, Nair SV, Tetsuya F, Hirroshi T. Chitin scaffolds in tissue engineering. Int J Mol Sci. 2011;12: 1876-1887.
7. Tripathi A, Saravanan S, Pattnaik S, Moorthi A, Partridge NC, Selvamurugan N. Bio-composite scaffolds containing chitosan/nano-hydroxyapatite/nano-copper-zinc for bone tissue engineering. Int J Biol Macromol. 2012;50:294-299.
8. Eugene JC, Eric LH, Bradley KW. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11:471-491.
9. Scott JH, William LM. Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev. 2011;17:459-474.
10. van Hout WM, Mink van der Molen AB, Breugem CC, Koole R, Van Cann EM. Reconstruction of the alveolar cleft: can growth factor-aided tissue engineering replace autologous bone grafting? A literature review and systematic review of results obtained with bone morphogenetic protein-2. Clin Oral Investig. 2011;15:297-303.
11. Boraiah S, Paul O, Hawkes D, Wickham M, Lorich DG. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin Orthop Relat Res. 2009;467:3257-3262.
12. Hardeep S, Eric J, Ho-Man K, Lakshmi NS. Fabrication and evaluation of resveratrol loaded polymeric nanofibers. J Biomater Tissue Eng. 2012;2:228-235.
13. Dai Z, Li Y, Quarles LD, et al. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 2007;14:806-814.
14. Suzuki A, Guicheux J, Palmer G, et al. Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone. 2002;30:91-98.
15. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun. 1998;253:859-863.
16. Santos AC, Veiga F, Ribeiro AJ. New delivery systems to improve the bioavailability of resveratrol. Expert Opin Drug Deliv. 2011;8:973-990.
17. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res. 2010;54:7-16.
18. Merodio M, Arnedo A, Renedo MJ, Irache JM. Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. Eur J Pharm Sci. 2001;12:251-259.
19. Chuenjitkuntaworn B, Inrung W, Damrongsri D, Mekaapiruk K, Supaphol P, Pavasant P. Polycaprolactone/hydroxyapatite composite scaffolds: preparation, characterization, and in vitro and in vivo biological responses of human primary bone cells. J Biomed Mater Res A. 2010;94:241-251.
20. Dhanasekaran M, Indumathi S, Lissa RP, Harikrishnan R, Rajkumar JS, Sudarsanam D. A comprehensive study on optimization of proliferation and differentiation potency of bone marrow derived mesenchymal stem cells under prolonged culture condition. Cytotechnology. 2013;65:187-197.
21. Sittichokechaiwut A, Edwards JH, Scutt AM, Reilly GC. Short bouts of mechanical loading are as effective as dexamethasone at inducing matrix production by human bone marrow mesenchymal stem cells. Eur Cell Mater. 2012;20:45-57.
22. Gomide V, Zonari AAC, Breyner NM, Goes AM, Pereira MM. ISRN Materials Science. Attachment and proliferation of human-adipose-tissue-derived stem cells on bioactive glass/PVA hybrid scaffolds. Available from: http://www.hindawi.com/isrn/ms/2011/240864/. Accessed August 16, 2013.
23. Ahmed SS, Santosh W, Kumar S, Christlet HT. Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Sci. 2009;16:63.
24. Niranjan R, Koushik C, Saravanan S, Moorthi A, Vairamani M, Selvamurugan N. A novel injectable temperature-sensitive zinc doped chitosan/β-glycerophosphate hydrogel for bone tissue engineering. Int J Biol Macromol. 2013;54:24-29.
25. Mendes JB, Riekes MK, de Oliveira VM, et al. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. Scientific World Journal. 2012;2012:542937.